Qiagen said on that it has received several “conditional, non-binding indications of interest” from potential merger or acquisition partners.
As such, the company has begun a review of potential strategic alternatives, it said.
The company also noted that there is no guarantee or certainty that these discussions to a recommended firm offer to all shareholders of the company.
The announcement comes in the wake of a media report on that Thermo Fisher Scientific had approached Qiagen about a potential buyout. Qiagen officials had declined to comment at that time.